|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 3.680 CAD | -1.34% |
|
+7.29% | +36.30% |
| 07-28 | BioRem Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 | CI |
| 07-28 | BioRem Q2 Net Earnings Rise to C$0.11 Per Share | MT |
Evolution of the Average Target: BioRem Inc.
Evolution of the Target Price: BioRem Inc.
Changes in Analyst Recommendations: BioRem Inc.
ce7f9a173dbb01890bfe5bbcf8729.vBYSi97buBlonMFQI_9IAcHdzMJpvehki839VMGB-pA.03srwbTr3SEv36thTJpxOKqOk_Qz-6405YmvMJDmraDxbCO7lbrRKFvqog~7e673b6aaa89c4f8eaf618aa5d7e156e
| Consensus | Analysts' recommendations evolution (4 months) | Financial estimates divergence | Analysts' Target price divergence | Objective/dr gap | ||
|---|---|---|---|---|---|---|
 | - | - | +22.28% | |||
| +34.68% | |||||
| -1.57% | |||||
| +37.82% | |||||
| +57.41% | |||||
| - | - | +18.21% | |||
| +42.28% | |||||
| Average | +30.16% | |||||
| Weighted average by Cap. | +26.09% |
Analysts' Consensus
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
1
Last Close Price
3.680CAD
Average target price
4.500CAD
Spread / Average Target
+22.28%
High Price Target
4.500CAD
Spread / Highest target
+22.28%
Low Price Target
4.500CAD
Spread / Lowest Target
+22.28%
Analyst Consensus Detail
Consensus revision (last 18 months)
SellBuy
Mean consensus
OUTPERFORM
Number of Analysts
1
Last Close Price
3.680CAD
Average target price
4.500CAD
Spread / Average Target
+22.28%
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- BRM Stock
- Consensus BioRem Inc.
Select your edition
All financial news and data tailored to specific country editions
